Evidence map›Paper›PMID 20085439›Full record

ReviewTissue engineering. Part B, Reviews2010

Cell-seeding techniques in vascular tissue engineering.

Gustavo A Villalona, Brooks Udelsman, Daniel R Duncan, Edward McGillicuddy, Rajendra F Sawh-Martinez, Narutoshi Hibino, Christopher Painter, Tamar Mirensky, Benjamin Erickson, Toshiharu Shinoka and 1 more

Abstract readReview
In one paragraph

Review in Tissue engineering. Part B, Reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed.

  1. Article
  2. Article
  3. Bioreactor Design and Engineering for Cultivated Meat Manufacturing.Advances in biochemical engineering/biotechnology · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gustavo A VillalonaDepartment of Surgery, Yale University School of Medicine, Yale New Haven Hospital, New Haven, Connecticut 06520-8062, USA.
Brooks Udelsman
Daniel R Duncan
Edward McGillicuddy
Rajendra F Sawh-Martinez
Narutoshi Hibino
Christopher Painter
Tamar Mirensky
Benjamin Erickson
Toshiharu Shinoka
Christopher K Breuer

Funding

Development of Second Generation Tissue Engineered Vascular GraftsK08HL083980 · NHLBI · YALE UNIVERSITY · PI BREUER, CHRISTOPHER KANE · 2006 to 2010
$666k
NHLBI NIH HHS K08HL83980-2
6 · The paper itself

Abstract

Previous studies have demonstrated the benefits of cell seeding in the construction of tissue-engineered vascular grafts (TEVG). However, seeding methods are diverse and no method is clearly superior in either promoting seeding efficiency or improving long-term graft function. As we head into an era during which a variety of different TEVG are under investigation in clinical trials around the world, it is important to consider the regulatory issues surrounding the translation of these technologies. In this review, we summarize important advances in the field of vascular tissue engineering, with particular attention on cell-seeding techniques for TEVG development and special emphasis placed on regulatory issues concerning the clinical translation of these various methods.

Indexed as

Tissue ScaffoldsBlood Vessel ProsthesisBlood VesselsBone Marrow TransplantationCell Culture TechniquesCell TransplantationEndothelial CellsGuided Tissue RegenerationHumansModels, BiologicalMyocytes, Smooth MuscleTissue Engineering

Identifiers

PMID20085439
PMCPMC2946885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.